Evidence supports the use of multidisciplinary team meetings

Abstract

A recent systematic review of MDTMs for patients with GI cancers confirmed their value in improving quality of care. According to the 9 published articles identified by the researchers that included data regarding discussions of treatment plans during MDTMs, changes in treatment were discussed by the meeting participants in 23.0% to 41.7% of evaluated cases. The systematic review also determined that treatment plans formulated during MDTMs are implemented in 90% to 100% of discussed patients, according to the 4 articles that reported this outcome.